Halozyme Therapeutics Inc (HALO)
40.65
-0.08
(-0.20%)
USD |
NASDAQ |
Mar 28, 16:00
40.65
0.00 (0.00%)
After-Hours: 20:00
Halozyme Therapeutics Cash from Investing (TTM): -96.91M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -96.91M |
September 30, 2023 | -90.36M |
June 30, 2023 | -7.922M |
March 31, 2023 | -497.86M |
December 31, 2022 | -487.00M |
September 30, 2022 | -784.73M |
June 30, 2022 | -800.67M |
March 31, 2022 | -410.34M |
December 31, 2021 | -406.29M |
September 30, 2021 | -48.38M |
June 30, 2021 | -61.52M |
March 31, 2021 | -5.005M |
December 31, 2020 | 78.35M |
September 30, 2020 | -102.90M |
June 30, 2020 | -31.81M |
March 31, 2020 | 3.747M |
December 31, 2019 | -5.549M |
September 30, 2019 | 128.08M |
June 30, 2019 | 122.27M |
March 31, 2019 | 67.21M |
December 31, 2018 | 2.493M |
September 30, 2018 | -157.30M |
June 30, 2018 | -162.21M |
March 31, 2018 | -203.90M |
December 31, 2017 | -163.73M |
Date | Value |
---|---|
September 30, 2017 | 6.301M |
June 30, 2017 | -15.74M |
March 31, 2017 | 33.12M |
December 31, 2016 | -76.77M |
September 30, 2016 | -112.57M |
June 30, 2016 | -100.52M |
March 31, 2016 | -89.31M |
December 31, 2015 | 5.888M |
September 30, 2015 | 34.13M |
June 30, 2015 | 16.46M |
March 31, 2015 | -0.18M |
December 31, 2014 | -32.95M |
September 30, 2014 | -44.42M |
June 30, 2014 | -47.37M |
March 31, 2014 | -41.58M |
December 31, 2013 | -47.87M |
September 30, 2013 | -50.43M |
June 30, 2013 | -50.27M |
March 31, 2013 | -50.91M |
December 31, 2012 | -1.413M |
September 30, 2012 | -1.430M |
June 30, 2012 | -1.302M |
March 31, 2012 | -0.6096M |
December 31, 2011 | -0.8285M |
September 30, 2011 | -0.6023M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-800.67M
Minimum
Jun 2022
128.08M
Maximum
Sep 2019
-171.88M
Average
-54.95M
Median
Cash from Investing (TTM) Benchmarks
Johnson & Johnson | 878.00M |
Globus Medical Inc | 302.97M |
AIM ImmunoTech Inc | 2.745M |
Protalix BioTherapeutics Inc | -16.71M |
Armata Pharmaceuticals Inc | -8.134M |